Reducing cystoscopy for blood in urine
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if we can safely skip a bladder camera test (cystoscopy) for people who have microscopic blood in their urine. If you meet certain criteria, you may not need the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have microscopic blood in your urine (seen only under a microscope)
- Men must be 40 or older
- Women must be 50 or older
- You have never had bladder or urinary tract cancer
- You do not have visible blood in your urine
- If you are a woman, you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether women over 50 with visible blood in their urine need extra tests after a bladder infection. It aims to find out if they need a camera test (cystoscopy) to check for cancer.
This study tests a simple urine test that may help figure out if people with tiny amounts of blood in their urine (not visible to the eye) are at risk for bladder cancer. The goal is to see if this test can help doctors decide who needs more checks.
This trial checks whether a new lab test on urine can help sort out which people with small amounts of blood in the urine (microscopic hematuria) might have bladder cancer. It may help doctors evaluate symptoms more accurately and decide who needs further testing.
This trial is testing a urine test called Bladder EpiCheck to see if it can help find bladder cancer in people who have blood in their urine. You would give a urine sample and then have a standard cystoscopy as part of your care.
This study tests a simple urine test that looks for DNA changes to help find bladder or urinary tract cancer early. It is for people who have blood in their urine and are going to have surgery, to see if the test can accurately detect cancer before surgery.
This study collects urine samples to test UroAmp, a new genetic test that may help detect and monitor bladder cancer. It is for people with bladder cancer or blood in urine who want to help improve cancer detection.
Hear when a new Hematuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.